| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Revenue | ~$7.8B (Q3) | Not provided standalone | Merged guidance obscures clean comparison |
| Adjusted Operating EPS | $3.04 (Q3) vs $2.86 (Q3 2024) | $9.39 (FY 2025) vs guidance | Beat midpoint 4th consecutive year |
| 2026 EPS Guidance | Not provided | $11.00-$12.00 | Initial combined company guidance |
| Base EPS CAGR | Not disclosed | 20% through 2029 | New multi-year visibility framework |
| Enhanced Earnings % of Total | Not quantified | 40% in 2026, trending to 30-35% | Large unmodeled earnings component disclosed |
| Free Cash Flow 2026-27 | ~$2B incremental from Calpine | $8.4B combined | Includes asset sale proceeds |
| Share Buyback Authorization | $600M remaining | $5B total authorization | 733% increase in buyback capacity |
| Contracted Nuclear MWh 2030 | 12 million MWh | 48 million MWh | 300% increase in contracted position |
| Available Nuclear MWh | ~183 million total | 147 million uncontracted | Still massive optionality despite contracting |
| Growth CapEx 2026-27 | Not specified | $3.9B committed | 10%+ unlevered IRR threshold |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.